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The first prophylactic vaccine against hepatitis E virus (HEV), Hecolin®, was licensed in China. Recombinant 
p239 virus-like particle (VLP) is its active component with dimeric protein as the basic building block harboring 
the immuno dominant and neutralizing epitopes. The real time and real condition stability of the prefilled 
syringes for the vaccine was demonstrated using both in vivo mouse potency and in vitro antigenicity assays. A 
total of 12 lots of Hecolin® were assessed with a set of assays after storage at 2-8 °C for 24 months. The 
particle characteristics of p239 VLP recovered from the aluminum-containing adjuvant was assessed with 
different methods including analytical ultracentrifugation, high performance size exclusion chromatography and 
transmission electron microscopy. The thermal and conformational stability of the adsorbed antigen was 
assessed using differential scanning calorimetry. The protein integrity of the recovered p239 antigen was 
demonstrated using SDS-PAGE with silvering staining, LC-MS and MALDI-TOF MS. Most importantly, the 
binding activity to the neutralizing antibody or vaccine antigenicity was measured using an epitope-specific and 
real-time SPR assay and a monoclonal antibody-based sandwich ELISA. Taken together, the overall good 
stability of the Hecolin® prefilled syringes was demonstrated with unaltered molecular and functional attributes 
after storage at 2-8 °C for 24 months. 
 
 
 
